PLA2G16 anticorps (AA 68-162)

N° du produit ABIN7267786

Détail du produit anti-PLA2G16 anticorps

Antigène: PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))

Épitope: AA 68-162

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G16 est non-conjugé

Application: Western Blotting (WB)

Fonction: PLA2G16 Rabbit pAb

Séquence: VAGSDKYQVN NKHDDKYSPL PCSKIIQRAE ELVGQEVLYK LTSENCEHFV NELRYGVARS DQVRDVIIAA SVAGMGLAAM SLIGVMFSRN KRQKQ

Réactivité croisée: Humain

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 68-162 of human PLA2G16 (NP_009000.2).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur PLA2G16

Antigène: PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))

Autre désignation: PLA2G16 (PLA2G16 Produits)

Synonymes: anticorps HRASLS3, anticorps HREV107, anticorps HRSL3, anticorps AdPLA, anticorps H-REV107-1, anticorps HREV107-1, anticorps HREV107-3, anticorps C78643, anticorps Hrasls3, anticorps Hrev107, anticorps MLP-3, anticorps phospholipase A2 group XVI, anticorps phospholipase A2, group XVI, anticorps PLA2G16, anticorps Pla2g16

Sujet: Exhibits both phospholipase A1/2 and acyltransferase activities. Shows phospholipase A1 (PLA1 and A2 (PLA2 activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids. For most substrates, PLA1 activity is much higher than PLA2 activity. Shows O-acyltransferase activity,catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid. Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE, forming N-acylphosphatidylethanolamine (NAPE, which serves as precursor for N-acylethanolamines (NAEs. Exhibits high N-acyltransferase activity and low phospholipase A1/2 activity. Required for complete organelle rupture and degradation that occur during eye lens terminal differentiation, when fiber cells that compose the lens degrade all membrane-bound organelles in order to provide lens with transparency to allow the passage of light. Organelle membrane degradation is probably catalyzed by the phospholipase activity (By similarity.,PLA2G16,AdPLA,H-REV107,H-REV107-1,HRASLS3,HREV107,HREV107-1,HREV107-3,HRSL3,Cancer,Tumor suppressors,PLA2G16

Poids moléculaire: 18kDa

ID gène: 11145

UniProt: P53816

Pathways: Inositol Metabolic Process